Endocrine disrupting effects of zearalenone, alpha- and beta-zearalenol at the level of nuclear receptor binding and steroidogenesis
C. Frizzell
1
,
D Ndossi
2, 3
,
Steven Verhaegen
4, 5
,
E. Dahl
4, 5
,
Gunnar Sundstøl Eriksen
6
,
M Sørlie
7
,
E. Ropstad
4, 5
,
Marc Muller
8
,
Christopher S. Elliott
9
,
L Connolly
9
2
Norwegian School of Veterinary Science, Oslo, Norway
|
4
Norwegian School of Veterinary Science
5
Oslo Norway
|
6
National Veterinary Institute, Oslo, Norway
|
9
School of Biological Sciences
Publication type: Journal Article
Publication date: 2011-10-01
scimago Q2
wos Q2
SJR: 0.767
CiteScore: 5.9
Impact factor: 2.9
ISSN: 03784274, 18793169
PubMed ID:
21803136
General Medicine
Toxicology
Abstract
The mycotoxin zearalenone (ZEN) is a secondary metabolite of fungi which is produced by certain species of the genus Fusarium and can occur in cereals and other plant products. Reporter gene assays incorporating natural steroid receptors and the H295R steroidogenesis assay have been implemented to assess the endocrine disrupting activity of ZEN and its metabolites α-zearalenol (α-ZOL) and β-zearalenol (β-ZOL). α-ZOL exhibited the strongest estrogenic potency (EC(50) 0.022±0.001 nM), slightly less potent than 17-β estradiol (EC(50) 0.015±0.002 nM). ZEN was ~70 times less potent than α-ZOL and twice as potent as β-ZOL. Binding of progesterone to the progestagen receptor was shown to be synergistically increased in the presence of ZEN, α-ZOL or β-ZOL. ZEN, α-ZOL or β-ZOL increased production of progesterone, estradiol, testosterone and cortisol hormones in the H295R steroidogenesis assay, with peak productions at 10 μM. At 100 μM, cell viability decreased and levels of hormones were significantly reduced except for progesterone. β-ZOL increased estradiol concentrations more than α-ZOL or ZEN, with a maximum effect at 10 μM, with β-ZOL (562±59 pg/ml)>α-ZOL (494±60 pg/ml)>ZEN (375±43 pg/ml). The results indicate that ZEN and its metabolites can act as potential endocrine disruptors at the level of nuclear receptor signalling and by altering hormone production.
Found
Nothing found, try to update filter.
Found
Nothing found, try to update filter.
Top-30
Journals
|
5
10
15
20
25
|
|
|
Toxins
21 publications, 11.17%
|
|
|
Food and Chemical Toxicology
13 publications, 6.91%
|
|
|
Toxicology Letters
11 publications, 5.85%
|
|
|
Toxicon
10 publications, 5.32%
|
|
|
World Mycotoxin Journal
6 publications, 3.19%
|
|
|
Environmental International
5 publications, 2.66%
|
|
|
Toxicology in Vitro
5 publications, 2.66%
|
|
|
Environmental Toxicology and Pharmacology
5 publications, 2.66%
|
|
|
Journal of Agricultural and Food Chemistry
5 publications, 2.66%
|
|
|
Molecules
4 publications, 2.13%
|
|
|
Mycotoxin Research
4 publications, 2.13%
|
|
|
International Journal of Molecular Sciences
3 publications, 1.6%
|
|
|
Ecotoxicology and Environmental Safety
3 publications, 1.6%
|
|
|
Reproductive Toxicology
3 publications, 1.6%
|
|
|
Environmental Pollution
3 publications, 1.6%
|
|
|
Theriogenology
3 publications, 1.6%
|
|
|
Critical Reviews in Food Science and Nutrition
3 publications, 1.6%
|
|
|
Archives of Toxicology
2 publications, 1.06%
|
|
|
Environmental Science and Pollution Research
2 publications, 1.06%
|
|
|
Toxicology and Applied Pharmacology
2 publications, 1.06%
|
|
|
Science of the Total Environment
2 publications, 1.06%
|
|
|
Food Chemistry
2 publications, 1.06%
|
|
|
Regulatory Toxicology and Pharmacology
2 publications, 1.06%
|
|
|
Chemosphere
2 publications, 1.06%
|
|
|
NFS Journal
2 publications, 1.06%
|
|
|
ACS Catalysis
2 publications, 1.06%
|
|
|
Food and Function
2 publications, 1.06%
|
|
|
Environmental Chemistry
1 publication, 0.53%
|
|
|
Environmental Health Perspectives
1 publication, 0.53%
|
|
|
5
10
15
20
25
|
Publishers
|
10
20
30
40
50
60
70
80
90
100
|
|
|
Elsevier
93 publications, 49.47%
|
|
|
MDPI
34 publications, 18.09%
|
|
|
Springer Nature
14 publications, 7.45%
|
|
|
Taylor & Francis
9 publications, 4.79%
|
|
|
American Chemical Society (ACS)
8 publications, 4.26%
|
|
|
Wageningen Academic Publishers
6 publications, 3.19%
|
|
|
Wiley
4 publications, 2.13%
|
|
|
Royal Society of Chemistry (RSC)
4 publications, 2.13%
|
|
|
Frontiers Media S.A.
2 publications, 1.06%
|
|
|
Oxford University Press
2 publications, 1.06%
|
|
|
CSIRO Publishing
1 publication, 0.53%
|
|
|
Environmental Health Perspectives
1 publication, 0.53%
|
|
|
Walter de Gruyter
1 publication, 0.53%
|
|
|
Instituto Brasileiro de Estudos e Pesquisas de Gastroenterologia/Brazilian Institute for Studies and Research in Gastroenterology
1 publication, 0.53%
|
|
|
Veterinary World
1 publication, 0.53%
|
|
|
KenzPub
1 publication, 0.53%
|
|
|
American Society of Animal Science
1 publication, 0.53%
|
|
|
Japanese Society of Toxicology
1 publication, 0.53%
|
|
|
International Society for Horticultural Science (ISHS)
1 publication, 0.53%
|
|
|
Cold Spring Harbor Laboratory
1 publication, 0.53%
|
|
|
Mary Ann Liebert
1 publication, 0.53%
|
|
|
10
20
30
40
50
60
70
80
90
100
|
- We do not take into account publications without a DOI.
- Statistics recalculated weekly.
Are you a researcher?
Create a profile to get free access to personal recommendations for colleagues and new articles.
Metrics
188
Total citations:
188
Citations from 2024:
17
(9.04%)
Cite this
GOST |
RIS |
BibTex |
MLA
Cite this
GOST
Copy
Frizzell C. et al. Endocrine disrupting effects of zearalenone, alpha- and beta-zearalenol at the level of nuclear receptor binding and steroidogenesis // Toxicology Letters. 2011. Vol. 206. No. 2. pp. 210-217.
GOST all authors (up to 50)
Copy
Frizzell C., Ndossi D., Verhaegen S., Dahl E., Eriksen G. S., Sørlie M., Ropstad E., Muller M., Elliott C. S., Connolly L. Endocrine disrupting effects of zearalenone, alpha- and beta-zearalenol at the level of nuclear receptor binding and steroidogenesis // Toxicology Letters. 2011. Vol. 206. No. 2. pp. 210-217.
Cite this
RIS
Copy
TY - JOUR
DO - 10.1016/j.toxlet.2011.07.015
UR - https://doi.org/10.1016/j.toxlet.2011.07.015
TI - Endocrine disrupting effects of zearalenone, alpha- and beta-zearalenol at the level of nuclear receptor binding and steroidogenesis
T2 - Toxicology Letters
AU - Frizzell, C.
AU - Ndossi, D
AU - Verhaegen, Steven
AU - Dahl, E.
AU - Eriksen, Gunnar Sundstøl
AU - Sørlie, M
AU - Ropstad, E.
AU - Muller, Marc
AU - Elliott, Christopher S.
AU - Connolly, L
PY - 2011
DA - 2011/10/01
PB - Elsevier
SP - 210-217
IS - 2
VL - 206
PMID - 21803136
SN - 0378-4274
SN - 1879-3169
ER -
Cite this
BibTex (up to 50 authors)
Copy
@article{2011_Frizzell,
author = {C. Frizzell and D Ndossi and Steven Verhaegen and E. Dahl and Gunnar Sundstøl Eriksen and M Sørlie and E. Ropstad and Marc Muller and Christopher S. Elliott and L Connolly},
title = {Endocrine disrupting effects of zearalenone, alpha- and beta-zearalenol at the level of nuclear receptor binding and steroidogenesis},
journal = {Toxicology Letters},
year = {2011},
volume = {206},
publisher = {Elsevier},
month = {oct},
url = {https://doi.org/10.1016/j.toxlet.2011.07.015},
number = {2},
pages = {210--217},
doi = {10.1016/j.toxlet.2011.07.015}
}
Cite this
MLA
Copy
Frizzell, C., et al. “Endocrine disrupting effects of zearalenone, alpha- and beta-zearalenol at the level of nuclear receptor binding and steroidogenesis.” Toxicology Letters, vol. 206, no. 2, Oct. 2011, pp. 210-217. https://doi.org/10.1016/j.toxlet.2011.07.015.